These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38595234)

  • 1. [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma].
    Cai X; Wang R; Wang S; Ren Z; Yu Q; Li D
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):199-206. PubMed ID: 38595234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM.
    Zhao S; Ni K; Xie J; Cheng C; Zhao N; Liu J; Ji W; Wang Q; Zhang P; Liu Y
    J Neurooncol; 2024 Oct; 170(1):101-117. PubMed ID: 39143438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
    Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
    Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective.
    Wang L; Li X; Xu C; Wang D; Ma C; Wang Z; Li Y; Li Z
    J Transl Med; 2024 Jun; 22(1):551. PubMed ID: 38851695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level.
    Liu P; Xing N; Xiahou Z; Yan J; Lin Z; Zhang J
    Front Immunol; 2024; 15():1368685. PubMed ID: 38510250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
    Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
    Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
    Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
    CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 16. The CEBPB
    Yang Y; Jin X; Xie Y; Ning C; Ai Y; Wei H; Xu X; Ge X; Yi T; Huang Q; Yang X; Jiang T; Wang X; Piao Y; Jin X
    Theranostics; 2024; 14(10):4107-4126. PubMed ID: 38994023
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
    Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
    Wang K; Huang R; Tong X; Wang Z; Sun S; Wu C
    Biomed Res Int; 2021; 2021():5579359. PubMed ID: 34373835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics.
    Xing J; Cai H; Lin Z; Zhao L; Xu H; Song Y; Wang Z; Liu C; Hu G; Zheng J; Ren L; Wei Z
    Front Immunol; 2023; 14():1288137. PubMed ID: 38274828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.